Bioventix PLC Stock OTC Markets
Stocks
BVNXF
GB00B4QVDF07
Biotechnology & Medical Research
OTC Markets Traded|
Real-time
OTC Markets
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-.--% | - |
| 03-30 | BioVentix confident on future despite profit decline in first half | AN |
| 03-30 | WINNERS & LOSERS: boohoo to beat view; Abingdon Health wins deals | AN |
| Market Cap | 86.21M 114M 101M 95.05M 162M 10.97B 163M 1.14B 440M 5.6B 429M 420M 17.99B | P/E 2026 * |
12.3x | P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 81.32M 108M 94.81M 89.65M 153M 10.35B 154M 1.07B 415M 5.28B 405M 396M 16.97B | EV / Sales 2026 * |
6.51x | EV / Sales 2027 * | - |
| Free-Float |
92.29% | Yield 2026 * |
9.09% | Yield 2027 * | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Peter Harrison
CEO | Chief Executive Officer | 67 | 23/12/2003 |
| Director of Finance/CFO | 67 | 01/07/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Peter Harrison
BRD | Director/Board Member | 67 | 25/11/2010 |
Ian Nicholson
CHM | Chairman | 66 | 01/11/2004 |
| Director/Board Member | 67 | 01/07/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 114M | |
| -0.07% | +3.66% | +12.24% | +37.08% | 49.06B | |
| -1.49% | -1.21% | +47.64% | +35.61% | 44.6B | |
| -0.49% | +4.03% | +335.48% | +624.80% | 43.24B | |
| -1.68% | -2.28% | +8.07% | +99.96% | 41.73B | |
| +0.51% | -1.71% | +5.18% | +46.87% | 29.93B | |
| -0.23% | -2.22% | +23.05% | +154.50% | 17.19B | |
| -1.37% | +8.96% | +7.04% | - | 15.35B | |
| -2.26% | -2.61% | +26.48% | +43.74% | 15.54B | |
| -2.39% | -5.84% | - | - | 15.11B | |
| Average | -0.97% | +1.85% | +58.15% | +148.94% | 30.19B | |
| Weighted average by Cap. | -0.92% | +2.26% | +72.63% | +163.01% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 12.5M 16.57M 14.57M 13.78M 23.48M 1.59B 23.61M 165M 63.73M 812M 62.21M 60.87M 2.61B | - |
| Net income | 7.11M 9.43M 8.29M 7.84M 13.36M 905M 13.43M 93.88M 36.26M 462M 35.4M 34.63M 1.48B | - |
| Net Debt | -4.89M -6.49M -5.71M -5.4M -9.19M -623M -9.24M -64.6M -24.95M -318M -24.36M -23.83M -1.02B | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BVXP Stock
- BVNXF Stock
Select your edition
All financial news and data tailored to specific country editions
